{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:35:16Z","timestamp":1782776116456,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00277-019-03890-w","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T09:02:59Z","timestamp":1578301379000},"page":"229-239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hypercalcemia is associated with a poor prognosis in lymphoma a retrospective monocentric matched-control study and extensive review of published reported cases"],"prefix":"10.1007","volume":"99","author":[{"given":"Nicolas","family":"Vallet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Ertault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Delaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Chalopin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Villate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurianne","family":"Drieu La Rochelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Lejeune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Foucault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Eloit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Barin-Le Guellec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"H\u00e9rault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Colombat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Gyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"issue":"7","key":"3890_CR1","doi-asserted-by":"publisher","first-page":"e015106","DOI":"10.1136\/bmjopen-2016-015106","volume":"17","author":"X Ye","year":"2017","unstructured":"Ye X, Mahmud S, Skrabek P et al (2017) Long-term time trends in incidence, survival and mortality of lymphomas by subtype among adults in Manitoba, Canada: a population-based study using cancer registry data. BMJ Open 17(7):e015106. https:\/\/doi.org\/10.1136\/bmjopen-2016-015106","journal-title":"BMJ Open"},{"key":"3890_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"International Non-Hodgkin's Lymphoma Prognostic Factors Project","year":"1993","unstructured":"International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med 329:987\u2013994. https:\/\/doi.org\/10.1056\/NEJM199309303291402","journal-title":"N Engl J Med"},{"key":"3890_CR3","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","volume":"104","author":"P Solal-C\u00e9ligny","year":"2004","unstructured":"Solal-C\u00e9ligny P, Roy P, Colombat P et al (2004) FLIPI: follicular lymphoma international prognostic index. Blood 104:1258\u20131265. https:\/\/doi.org\/10.1182\/blood-2003-12-4434","journal-title":"Blood"},{"key":"3890_CR4","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","volume":"339","author":"D Hasenclever","year":"1998","unstructured":"Hasenclever D, Diehl V, Armitage JO et al (1998) A prognostic score for advanced Hodgkin\u2019s disease. N Engl J Med 339:1506\u20131514. https:\/\/doi.org\/10.1056\/NEJM199811193392104","journal-title":"N Engl J Med"},{"key":"3890_CR5","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/10970142(19930215)71:4<1309","volume":"71","author":"R Vassilopoulou-Sellin","year":"1993","unstructured":"Vassilopoulou-Sellin R, Newman BM, Taylor SH, Guinee VF (1993) Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center. Cancer 71:1309\u20131312. https:\/\/doi.org\/10.1002\/10970142(19930215)71:4<1309","journal-title":"Cancer"},{"key":"3890_CR6","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1001\/archsurg.1980.01380060012004","volume":"115","author":"ME Burt","year":"1980","unstructured":"Burt ME, Brennan MF (1980) Incidence of hypercalcemia and malignant neoplasm. Arch Surg 115:704\u2013707. https:\/\/doi.org\/10.1001\/archsurg.1980.01380060012004","journal-title":"Arch Surg"},{"key":"3890_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jcp.55.8.637","volume":"55","author":"G Majumdar","year":"2002","unstructured":"Majumdar G (2002) Incidence and prognostic significance of hypercalcaemia in B-cell non-Hodgkin\u2019s lymphoma. J Clin Pathol 55:637\u2013638. https:\/\/doi.org\/10.1136\/jcp.55.8.637","journal-title":"J Clin Pathol"},{"key":"3890_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1056\/NEJMcp042806","volume":"352","author":"AF Stewart","year":"2005","unstructured":"Stewart AF (2005) Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 352:373\u2013379. https:\/\/doi.org\/10.1056\/NEJMcp042806","journal-title":"N Engl J Med"},{"key":"3890_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.11005\/jbm.2017.24.4.249","volume":"24","author":"J Jin","year":"2017","unstructured":"Jin J, Chung JO, Chung MY et al (2017) Clinical characteristics, causes and survival in 115 cancer patients with parathyroid hormone related protein-mediated hypercalcemia. J Bone Metab 24:249. https:\/\/doi.org\/10.11005\/jbm.2017.24.4.249","journal-title":"J Bone Metab"},{"key":"3890_CR10","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1182\/blood.V82.5.1383.1383","volume":"82","author":"JF Seymour","year":"1993","unstructured":"Seymour JF, Gagel RF (1993) Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphomas. Blood 82:1383\u20131394","journal-title":"Blood"},{"key":"3890_CR11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1359\/jbmr.2003.18.3.579","volume":"18","author":"M Hewison","year":"2003","unstructured":"Hewison M, Kantorovich V, Liker HR et al (2003) Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. J Bone Miner Res 18:579\u2013582. https:\/\/doi.org\/10.1359\/jbmr.2003.18.3.579","journal-title":"J Bone Miner Res"},{"key":"3890_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12885-0173113-z","volume":"17","author":"N Lehners","year":"2017","unstructured":"Lehners N, Kr\u00e4mer I, Saadati M et al (2017) Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvement. BMC Cancer 17:128. https:\/\/doi.org\/10.1186\/s12885-0173113-z","journal-title":"BMC Cancer"},{"key":"3890_CR13","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1016\/j.clml.2017.12.006","volume":"18","author":"RM Shallis","year":"2018","unstructured":"Shallis RM, Rome RS, Reagan JL (2018) Mechanisms of hypercalcemia in non-Hodgkin lymphoma and associated outcomes: a retrospective review. Clin Lymphoma Myeloma Leuk 18:e123\u2013e129. https:\/\/doi.org\/10.1016\/j.clml.2017.12.006","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"3890_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1136\/bmj.4.5893.643","volume":"4","author":"RB Payne","year":"1973","unstructured":"Payne RB, Little AJ, Williams RB, Milner JR (1973) Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J 4:643\u2013646","journal-title":"Br Med J"},{"key":"3890_CR15","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2017","unstructured":"R Core Team (2017) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna https:\/\/www.R-project.org"},{"key":"3890_CR16","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.clinbiochem.2012.04.025","volume":"45","author":"DB Endres","year":"2012","unstructured":"Endres DB (2012) Investigation of hypercalcemia. Clin Biochem 45:954\u2013963. https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.04.025","journal-title":"Clin Biochem"},{"key":"3890_CR17","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1210\/jcem-46-6-986","volume":"46","author":"JH Ladenson","year":"1978","unstructured":"Ladenson JH, Lewis JW, Boyd JC (1978) Failure of total calcium corrected for protein, albumin, and ph to correctly assess free calcium status. J Clin Endocrinol Metab 46:986\u2013993. https:\/\/doi.org\/10.1210\/jcem-46-6-986","journal-title":"J Clin Endocrinol Metab"},{"key":"3890_CR18","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/00000658-198511000-00009","volume":"202","author":"GP Zaloga","year":"1985","unstructured":"Zaloga GP, Chernow B, Cook D et al (1985) Assessment of calcium homeostasis in the critically ill surgical patient. The diagnostic pitfalls of the McLean-Hastings nomogram. Ann Surg 202:587\u2013594. https:\/\/doi.org\/10.1097\/00000658-198511000-00009","journal-title":"Ann Surg"},{"key":"3890_CR19","doi-asserted-by":"publisher","first-page":"633","DOI":"10.7326\/0003-4819-121-9-199411010-00001","volume":"121","author":"JF Seymour","year":"1994","unstructured":"Seymour JF, Gagel RF, Hagemeister FB, Dimopoulos MA, Cabanillas F (1994) Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma. Ann Intern Med 121:633\u2013640. https:\/\/doi.org\/10.7326\/0003-4819-121-9-199411010-00001","journal-title":"Ann Intern Med"},{"key":"3890_CR20","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1200\/JCO.2009.26.2493","volume":"28","author":"M Ziepert","year":"2010","unstructured":"Ziepert M, Hasenclever D, Kuhnt E et al (2010) Standard international prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era. J Clin Oncol 28:2373\u20132380. https:\/\/doi.org\/10.1200\/JCO.2009.26.2493","journal-title":"J Clin Oncol"},{"key":"3890_CR21","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1182\/blood-2006-01-013367","volume":"108","author":"C Buske","year":"2006","unstructured":"Buske C, Hoster E, Dreyling M, Hasford J, Unterhalt M, Hiddemann W (2006) The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome. Blood 108:1504\u20131508. https:\/\/doi.org\/10.1182\/blood-2006-01-013367","journal-title":"Blood"},{"key":"3890_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/sj.bmt.1702795","volume":"27","author":"A Salar","year":"2001","unstructured":"Salar A, Sierra J, Gandarillas M et al (2001) Autologous stem cell transplantation for clinically aggressive non-Hodgkin\u2019s lymphoma: the role of preparative regimens. Bone Marrow Transplant 27:405\u2013412. https:\/\/doi.org\/10.1038\/sj.bmt.1702795","journal-title":"Bone Marrow Transplant"},{"key":"3890_CR23","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1080\/10428190500054350","volume":"46","author":"E Jabbour","year":"2005","unstructured":"Jabbour E, Peslin N, Arnaud P, Ferme C, Carde P, Vantelon JM, Bocaccio C, Bourhis JH, Koscielny S, Ribrag V (2005) Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin\u2019s lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantation. Leuk Lymphoma 46:861\u2013867. https:\/\/doi.org\/10.1080\/10428190500054350","journal-title":"Leuk Lymphoma"},{"key":"3890_CR24","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.bbmt.2011.10.010","volume":"18","author":"N Mounier","year":"2012","unstructured":"Mounier N, Canals C, Gisselbrecht C, Cornelissen J, Foa R, Conde E, Maertens J, Attal M, Rambaldi A, Crawley C, Luan JJ, Brune M, Wittnebel S, Cook G, van Imhoff G, Pfreundschuh M, Sureda A, Lymphoma Working Party of European Blood and Marrow Transplantation Registry (EBMT) (2012) High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry. Biol Blood Marrow Transplant 18:788\u2013793. https:\/\/doi.org\/10.1016\/j.bbmt.2011.10.010","journal-title":"Biol Blood Marrow Transplant"},{"key":"3890_CR25","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/bmt.2013.83","volume":"48","author":"SP Robinson","year":"2013","unstructured":"Robinson SP, Canals C, Luang JJ, Tilly H, Crawley C, Cahn JY, Pohlreich D, le Gouill S, Gilleece M, Milpied N, Attal M, Biron P, Maury S, Rambaldi A, Maertens J, Capria S, Colombat P, Montoto S, Sureda A (2013) The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT. Bone Marrow Transplant 48:1409\u20131414. https:\/\/doi.org\/10.1038\/bmt.2013.83","journal-title":"Bone Marrow Transplant"},{"key":"3890_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/bjc.2014.277","volume":"111","author":"KT Troppan","year":"2014","unstructured":"Troppan KT, Schlick K, Deutsch A, Melchardt T, Egle A, Stojakovic T, Beham-Schmid C, Weiss L, Neureiter D, Wenzl K, Greil R, Neumeister P, Pichler M (2014) C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients. Br J Cancer 111:55\u201360. https:\/\/doi.org\/10.1038\/bjc.2014.277","journal-title":"Br J Cancer"},{"key":"3890_CR27","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00277-0142031-2","volume":"93","author":"S Dalia","year":"2014","unstructured":"Dalia S, Chavez J, Little B et al (2014) Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era. Ann Hematol 93:1305\u20131312. https:\/\/doi.org\/10.1007\/s00277-0142031-2","journal-title":"Ann Hematol"},{"key":"3890_CR28","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1359\/JBMR.040314","volume":"19","author":"Y Okada","year":"2004","unstructured":"Okada Y, Tsukada J, Nakano K, Tonai S, Mine S, Tanaka Y (2004) Macrophage inflammatory protein-1alpha induces hypercalcemia in adult T-cell leukemia. J Bone Miner Res 19:1105\u20131111. https:\/\/doi.org\/10.1359\/JBMR.040314","journal-title":"J Bone Miner Res"},{"key":"3890_CR29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1600-0609.2009.01405.x","volume":"84","author":"N Hattori","year":"2010","unstructured":"Hattori N, Nakamaki T, Ariizumi H, Homma M, Yamochi-Onizuka T, Ota H, Tomoyasu S (2010) Over-expression of CCL3 MIP-1alpha in a blastoid mantle cell lymphoma with hypercalcemia. Eur J Haematol 84:448\u2013452. https:\/\/doi.org\/10.1111\/j.1600-0609.2009.01405.x","journal-title":"Eur J Haematol"},{"key":"3890_CR30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/10428190310001593139","volume":"45","author":"Y Matsuhashi","year":"2004","unstructured":"Matsuhashi Y, Tasaka T, Uehara E, Fujimoto M, Fujita M, Tamura T, Honda T, Kuwajima M, Shimoura Y, Mano S, Nagai M, Ishida T (2004) Diffuse large B-cell lymphoma presenting with hypercalcemia and multiple osteolysis. Leuk Lymphoma 45:397\u2013400. https:\/\/doi.org\/10.1080\/10428190310001593139","journal-title":"Leuk Lymphoma"},{"key":"3890_CR31","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1200\/JCO.1997.15.3.1110","volume":"15","author":"P Brice","year":"1997","unstructured":"Brice P, Bastion Y, Lepage E, Brousse N, Ha\u00efoun C, Moreau P, Straetmans N, Tilly H, Tabah I, Solal-C\u00e9ligny P (1997) Comparison i low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d\u2019Etude des Lymphomes Folliculaires. Groupe d\u2019Etude des Lymphomes de l\u2019Adulte. J Clin Oncol 15:1110\u20131117. https:\/\/doi.org\/10.1200\/JCO.1997.15.3.1110","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03890-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-019-03890-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03890-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:10:54Z","timestamp":1609805454000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-019-03890-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,6]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["3890"],"URL":"https:\/\/doi.org\/10.1007\/s00277-019-03890-w","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,6]]},"assertion":[{"value":"17 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Helsinki Declaration and accepted by the ethical committee of our institution (project #2017-070, 11\/03\/2017). Patients provided written informed consent for data exploitation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}